Great Valley Advisor Group, Inc. Amgen Inc Transaction History

Great Valley Advisor Group, Inc.

$3.84 Billion
Q3 2024

A detailed history of Great Valley Advisor Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 17,908 shares of AMGN stock, worth $4.72 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

17,908

Previous 7,772 130.42%

Holding current value

$4.72 Million

Previous $2.43 Million 137.64%

% of portfolio

0.15%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $3.14 Million - $3.42 Million	10,136 Added 130.42%	17,908 $5.77 Million
Q2 2024 Jul 16, 2024	BUY	$262.75 - $319.31 $180,246 - $219,046	686 Added 9.68%	7,772 $2.43 Million
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $19,089 - $23,043	71 Added 1.01%	7,086 $2.01 Million
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $39,633 - $44,711	155 Added 2.26%	7,015 $2.02 Million
Q3 2023 Nov 06, 2023	SELL	$218.65 - $271.46 $62,096 - $77,094	-284 Reduced 3.98%	6,860 $1.84 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $118,705 - $140,366	-554 Reduced 7.2%	7,144 $1.59 Million
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $230,305 - $280,704	1,020 Added 15.27%	7,698 $1.86 Million
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $34,354 - $43,651	-150 Reduced 2.2%	6,678 $1.75 Million
Q3 2022 Oct 21, 2022	SELL	$224.46 - $253.15 $25,139 - $28,352	-112 Reduced 1.61%	6,828 $1.54 Million
Q2 2022 Jul 19, 2022	BUY	$230.71 - $256.74 $133,811 - $148,909	580 Added 9.12%	6,940 $1.69 Million
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $3,727 - $4,123	-17 Reduced 0.27%	6,360 $1.52 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $73,784 - $84,439	-371 Reduced 5.5%	6,377 $1.43 Million
Q3 2021 Oct 14, 2021	BUY	$212.27 - $248.7 $16,132 - $18,901	76 Added 1.14%	6,748 $1.44 Million
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $7,240 - $8,033	31 Added 0.47%	6,672 $1.63 Million
Q1 2021 Apr 20, 2021	SELL	$221.91 - $258.6 $25,741 - $29,997	-116 Reduced 1.72%	6,641 $1.65 Million
Q4 2020 Jan 29, 2021	BUY	$216.38 - $257.67 $77,680 - $92,503	359 Added 5.61%	6,757 $1.55 Million
Q3 2020 Oct 21, 2020	BUY	$234.65 - $260.95 $26,984 - $30,009	115 Added 1.83%	6,398 $1.63 Million
Q2 2020 Jul 31, 2020	BUY	$197.81 - $242.74 $117,894 - $144,673	596 Added 10.48%	6,283 $1.48 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $7,836 - $10,393	-43 Reduced 0.75%	5,687 $1.15 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $9,838 - $12,646	52 Added 0.92%	5,730 $1.38 Million
Q3 2019 Oct 25, 2019	BUY	$174.11 - $208.62 $522 - $625	3 Added 0.05%	5,678 $1.1 Million
Q2 2019 Jul 30, 2019	SELL	$166.7 - $195.41 $44,342 - $51,979	-266 Reduced 4.48%	5,675 $1.05 Million
Q1 2019 Apr 26, 2019	BUY	$180.87 - $203.88 $17,544 - $19,776	97 Added 1.66%	5,941 $1.13 Million
Q4 2018 Apr 11, 2019	BUY	$178.4 - $208.25 $1.04 Million - $1.22 Million	5,844 New	5,844 $1.14 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.

Account

Great Valley Advisor Group, Inc. Amgen Inc Transaction History